BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lok AS, Ganova-Raeva L, Cloonan Y, Punkova L, Lin HS, Lee WM, Ghany MG; Hepatitis B Research Network (HBRN). Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment. J Viral Hepat 2017;24:1032-42. [PMID: 28581155 DOI: 10.1111/jvh.12732] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 van Rijn-klink A, De Vries JJC, Claas ECJ. Next-Generation Sequencing in Clinical Virology. Application and Integration of Omics-powered Diagnostics in Clinical and Public Health Microbiology 2021. [DOI: 10.1007/978-3-030-62155-1_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Fergusson JR, Wallace Z, Connolly MM, Woon AP, Suckling RJ, Hine DW, Barber C, Bunjobpol W, Choi BS, Crespillo S, Dembek M, Dieckmann N, Donoso J, Godinho LF, Grant T, Howe D, McCully ML, Perot C, Sarkar A, Seifert FU, Singh PK, Stegmann KA, Turner B, Verma A, Walker A, Leonard S, Maini MK, Wiederhold K, Dorrell L, Simmons R, Knox A. Immune-Mobilizing Monoclonal T Cell Receptors Mediate Specific and Rapid Elimination of Hepatitis B-Infected Cells. Hepatology 2020;72:1528-40. [PMID: 32770836 DOI: 10.1002/hep.31503] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
3 Ciccullo A, Baldin G, Borghetti A, Di Giambenedetto S. Dolutegravir plus lamivudine for the treatment of HIV-1 infection. Expert Rev Anti Infect Ther 2020;18:279-92. [PMID: 32067525 DOI: 10.1080/14787210.2020.1729742] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
4 Escandón-felizzola VD. Recomendaciones en el tratamiento actual de la infección crónica por el virus de la hepatitis B. Hepatología 2020. [DOI: 10.52784/27112330.114] [Reference Citation Analysis]
5 Prasidthrathsint K, Stapleton JT. Laboratory Diagnosis and Monitoring of Viral Hepatitis. Gastroenterol Clin North Am 2019;48:259-79. [PMID: 31046974 DOI: 10.1016/j.gtc.2019.02.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
6 McNaughton AL, D'Arienzo V, Ansari MA, Lumley SF, Littlejohn M, Revill P, McKeating JA, Matthews PC. Insights From Deep Sequencing of the HBV Genome-Unique, Tiny, and Misunderstood. Gastroenterology 2019;156:384-99. [PMID: 30268787 DOI: 10.1053/j.gastro.2018.07.058] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 19.3] [Reference Citation Analysis]
7 Alacam S, Karabulut N, Yolcu A, Onel M, Atasoy A, Kaymakoglu S, Agacfidan A. Evaluation of drug resistance mutations in patients with chronic hepatitis B. Folia Microbiol (Praha) 2019;64:237-43. [PMID: 30259350 DOI: 10.1007/s12223-018-0650-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
8 NA Terrault, AS Lok, BJ McMahon, KM Chang, JP Hwang, MM Jonas, RS Brown, NH Bzowej, JB Wong. Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance. Hepatology 2018;67. [PMID: 29405329 DOI: 10.1002/hep.29800] [Cited by in Crossref: 1935] [Cited by in F6Publishing: 1925] [Article Influence: 387.0] [Reference Citation Analysis]
9 . Antiviral resistance. Reactions Weekly 2017;1677:43-43. [DOI: 10.1007/s40278-017-38321-6] [Reference Citation Analysis]